Metabolic Imaging by Positron Emission Tomography in Oncology

References

• Laniki L M. Positron emission tomography in oncology. Cancer 1996; 78: 2039–42
   PubMedGoogle Scholar
• Flier J S, Mueckler M M, Usher P, Lodish H F. Elevated levels of glucose transport and transporter messenger RNA are induced by ras and src oncogenes. Science 1987; 235: 1492–5
   PubMed Web of Science ®Google Scholar
• Weber G. Enzymology of cancer cells. N Engl J Med 1977; 296: 541–51
   PubMed Web of Science ®Google Scholar
• Hoffman R M. Altered methionine metabolism and transmethylation in cancer. Anticancer Res 1985; 5: 1–30
   PubMedGoogle Scholar
• Di Chiro G. Positron emission tomography using [18F]fluorodeoxyglucose in brain tumours. A powerful diagnostic and prognostic tool. Invest Radiol 1987; 22: 360–71
   PubMed Web of Science ®Google Scholar
• Lilja A, Bergstrom K, Hartvig P, et al. Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography. Am J Neuroradiol 1985; 6: 505–14
   PubMed Web of Science ®Google Scholar
• Derlon J -M, Bourdet C, Bustany R. et al. [11C]L-methionine uptake in gliomas. Neurosurgery 1989; 25: 720–8
   PubMedGoogle Scholar
• Ogawa T, Shishido F, Kanno I, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993; 186: 45–53
   PubMed Web of Science ®Google Scholar
• Mosskin M, von Hoist H, Bergström M, et al. Positron emission tomography with 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acfa. Radiol 1987; 28: 673–81
   Google Scholar
• Levivier M, Goldman S, Pirotte B, et al. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. J Neurosurg 1995; 82: 445–52
   PubMed Web of Science ®Google Scholar
• Pardo F S, Aronen H J, Kennedy D, et al. Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma. Int J Radiat Oncol Biol Phys 1994; 30: 663–9
   PubMedGoogle Scholar
• Want R L, Quint L E, Greenough R L, Meyer C R, White R I, Orringer M B. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371–7
   PubMedGoogle Scholar
• Knopp M V, Bischoff H, Ostertag H, et al. Clinical applications of FDG PET for staging of bronchogenic carcinoma. J Nucl Med 1993; 34: 21P, Abstr
   Google Scholar
• Jabour B A, Choi Y, Hoh C K, et al. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993; 186: 27–35
   PubMed Web of Science ®Google Scholar
• Braams J W, Pruim J, Freling J MF, et al. N. Detection of lymph node metastases of squamous cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995; 36: 211–6
   PubMedGoogle Scholar
• Rigo P, Paulus P, Kaschten B J, et al. Oncological applications of positron emission tomography with fluorine-18-fluorodeoxyglucose. Eur J Nucl Med 1996; 23: 1641–74
   PubMedGoogle Scholar
• Scott W J, Schwabe J L, Gupta N C, Dewan N A, Reeb S D, Sugimoto J T. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluoro-deoxyglucose. The members of the PET-Lung Tumor Study Group. Ann Thorac Surg 1994; 58: 698–703
   PubMedGoogle Scholar
• Lowe V J, Hoffman J M, DeLong D M, Patz E F, Jr, Coleman R E. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35: 1771–6
   PubMed Web of Science ®Google Scholar
• Lapela M, Grenman R, Kurki T, et al. Head and neck cancer. Detection of recurrence with positron emission tomography and 2-[18F]fluoro-2-deoxy-D-glucose. Radiology 1995; 197: 205–11
   PubMed Web of Science ®Google Scholar
• Lapela M, Leskinen S, Minn H, et al. Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood 1995; 86: 3522–7
   PubMed Web of Science ®Google Scholar
• Shields A F, Lim K, Grierson J, Link J, Krohn K A. Utilization of labeled thymidine in DNA synthesis: studies for PET. J Nucl Med 1987; 28: 1435–40
   PubMedGoogle Scholar
• Mintun M A, Welch M J, Siegel B A, et al. PET imaging of estrogen receptors. Radiology 1988; 169: 45–8
   PubMed Web of Science ®Google Scholar
• Minn H, Nuutila P, Lindholm P, et al. In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma. Cancer 1994; 1490–8
   PubMedGoogle Scholar